27th Mar 2008 07:01
Skyepharma PLC27 March 2008 SkyePharma PLC BOARD CHANGE LONDON, UK, 27 March 2008-- SkyePharma PLC (LSE: SKP) announces today that aftermore than nine years' service as a Non-Executive Director, Steve Harris hasdecided to resign from the Company with effect from the close of the Company'sAnnual General Meeting on 21 May 2008. He will be replaced as Chairman of theNomination & Governance Committee by Jeremy Scudamore and as a member of theRemuneration Committee by Jean-Charles Tschudin. Jeremy Scudamore, Non-Executive Chairman, said: "The Board is very grateful toSteve for his hard work, advice and commitment over the years. We wish him allthe best for the future." For further information please contact: SkyePharma PLC Frank Condella +44 20 7491 1777 Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113 Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has twelve approved products in the areas of oral,inhalation and topical delivery. The Group's products are marketed throughoutthe world by leading pharmaceutical companies. For more information, visitwww.skyepharma.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L